Arivale Inc. — Form D
Arivale Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-13. The offering totals $30.0M, of which $13.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-06-13
- Form: D
- Accession: 0001647380-17-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $13.6M
- Remaining: $16.4M
- Investors: 9
- Date of first sale: 2017-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-288607
Issuer
- Name: Arivale Inc.
- CIK: 0001647380
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2013
- Address: 710 SECOND AVE STE. 410, SEATTLE, WA, 98104
- Phone: 206-981-5821
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Tim Kilgallon | Director | Norwell, MA |
| Dan Levitan | Director | San Francisco, CA |
| Clayton Lewis | Director | Yorba Linda, CA |
| Terry McGuire | Director | Waltham, MA |
| Robert Nelsen | Director | Seattle, WA |
| Nathan Price | Director | Seattle, WA |
| Clayton Lewis | Executive Officer | Yorba Linda, CA |
Other filings by this issuer (1)
More